166 related articles for article (PubMed ID: 34237737)
1. Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis 1.
Kallionpää RA; Ahramo K; Martikkala E; Fazeli E; Haapaniemi P; Rokka A; Leivo I; Harvima IT; Peltonen J; Peltonen S
Dermatology; 2022; 238(2):329-339. PubMed ID: 34237737
[TBL] [Abstract][Full Text] [Related]
2. Mast cell tryptase and chymase in the progress of cutaneous vasculitis.
Lipitsä T; Naukkarinen A; Harvima IT
Arch Dermatol Res; 2015 Dec; 307(10):917-24. PubMed ID: 26498154
[TBL] [Abstract][Full Text] [Related]
3. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1.
Kallionpää RA; Peltonen S; Le KM; Martikkala E; Jääskeläinen M; Fazeli E; Riihilä P; Haapaniemi P; Rokka A; Salmi M; Leivo I; Peltonen J
Lab Invest; 2024 Jan; 104(1):100285. PubMed ID: 37949359
[TBL] [Abstract][Full Text] [Related]
5. Role of mast cell chymase and tryptase in the progression of atherosclerosis: study in 44 autopsied cases.
Ramalho LS; Oliveira LF; Cavellani CL; Ferraz ML; de Oliveira FA; Miranda Corrêa RR; de Paula Antunes Teixeira V; De Lima Pereira SA
Ann Diagn Pathol; 2013 Feb; 17(1):28-31. PubMed ID: 22658852
[TBL] [Abstract][Full Text] [Related]
6. Different patterns of mast cells distinguish diffuse from encapsulated neurofibromas in patients with neurofibromatosis 1.
Tucker T; Riccardi VM; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
J Histochem Cytochem; 2011 Jun; 59(6):584-90. PubMed ID: 21525187
[TBL] [Abstract][Full Text] [Related]
7. Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase.
Lipitsä T; Naukkarinen A; Laitala J; Harvima IT
Arch Dermatol Res; 2016 Oct; 308(8):575-84. PubMed ID: 27465068
[TBL] [Abstract][Full Text] [Related]
8. Mast cell phenotype in benign and malignant tumors of the prostate.
Globa T; Saptefrţi L; Ceauşu RA; Gaje P; Cimpean AM; Raica M
Pol J Pathol; 2014 Jun; 65(2):147-53. PubMed ID: 25119176
[TBL] [Abstract][Full Text] [Related]
9. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
Dyduch G; Okoń K; Pescarini E
Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
[TBL] [Abstract][Full Text] [Related]
10. Mast cell density and subtypes in the skin of Shar Pei dogs with cutaneous mucinosis.
Welle M; Grimm S; Suter M; von Tscharner C
Zentralbl Veterinarmed A; 1999 Jul; 46(5):309-16. PubMed ID: 10445005
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of tryptase in bovine cutaneous and tumor mast cells.
Welle MM; Proske SM; Harvima IT; Schechter NM
J Histochem Cytochem; 1995 Nov; 43(11):1139-44. PubMed ID: 7560896
[TBL] [Abstract][Full Text] [Related]
12. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
Huttunen M; Harvima IT
Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
[TBL] [Abstract][Full Text] [Related]
13.
Li Z; Ji C; Cheng J; Åbrink M; Shen T; Kuang X; Shang Z; Wu J
Bioengineered; 2022 May; 13(5):13752-13766. PubMed ID: 35746853
[TBL] [Abstract][Full Text] [Related]
14. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
[TBL] [Abstract][Full Text] [Related]
15. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study.
Horny HP; Greschniok A; Jordan JH; Menke DM; Valent P
J Clin Pathol; 2003 Feb; 56(2):103-6. PubMed ID: 12560387
[TBL] [Abstract][Full Text] [Related]
16. Thymosin beta 4 expression in normal skin, colon mucosa and in tumor infiltrating mast cells.
Nemolato S; Cabras T; Fanari MU; Cau F; Fraschini M; Manconi B; Messana I; Castagnola M; Faa G
Eur J Histochem; 2010 Feb; 54(1):e3. PubMed ID: 20353910
[TBL] [Abstract][Full Text] [Related]
17. Involvement of premacular mast cells in the pathogenesis of macular diseases.
Sato T; Morishita S; Horie T; Fukumoto M; Kida T; Oku H; Nakamura K; Takai S; Jin D; Ikeda T
PLoS One; 2019; 14(2):e0211438. PubMed ID: 30794552
[TBL] [Abstract][Full Text] [Related]
18. Semiquantitative aspects of mast cells in normal skin and in neurofibromas of neurofibromatosis types 1 and 5.
Nürnberger M; Moll I
Dermatology; 1994; 188(4):296-9. PubMed ID: 8193404
[TBL] [Abstract][Full Text] [Related]
19. Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses.
Ramu S; Akbarshahi H; Mogren S; Berlin F; Cerps S; Menzel M; Hvidtfeldt M; Porsbjerg C; Uller L; Andersson CK
BMC Immunol; 2021 Jun; 22(1):35. PubMed ID: 34078278
[TBL] [Abstract][Full Text] [Related]
20. [Tryptase- and chymase-positive mast cells as possible prognostic factor in patients with Hodgkin's lymphoma].
Rygoł B; Kyrcz-Krzemień S; Pajiak J; Konicki P; Kowai E; Gasińska T
Pol Arch Med Wewn; 2007; 117(1-2):27-32. PubMed ID: 17642203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
